
Lumosa Therapeutics Co., Ltd.
- Home
- Companies
- Lumosa Therapeutics Co., Ltd.
- News
- Lumosa`s CBO to Serve as Panel Judge ...
Lumosa`s CBO to Serve as Panel Judge for Innovator`s Pitch Challenge
Dec. 3, 2022
Courtesy ofLumosa Therapeutics Co., Ltd.
Lumosa`s Chief Business Officer, Mr. Christopher Aleong will be serving as one of the judges in the Innovator`s Pitch Challenge at the RESI (Redefining Early Stage Investments) Conference, on September 21~22, 2022. The Innovator’s Pitch Challenge (IPC) is an opportunity for early-stage life science and healthcare companies to gain additional exposure to conference attendees and pitch directly to a panel of judges, featuring active investors and industry experts.
The RESI conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development.
Stay in the loop!
Select your areas of interest to receive industry updates.